Series C funding round for Caribou Biosciences raising $120M in March 2021
Series C funding round for Caribou Biosciences raising $120M in March 2021
| Investor | Firm Type | Partner |
|---|---|---|
| Venture Capital |
| — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Angel | Adam Marchick |
| Angel | Sri Batchu |
| Angel | hugo angelmar |
| Angel | Dylan Taylor |
| Angel | Sung ho Choi |
| Angel | Ravi Grover |
| Angel | William Guo |
| Angel | Andy Rubin |
| Angel | Rob Meyerson |
| Angel | Richard Cooperstein |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$161M
Top Valuation
-
Caribou Biosciences raised $120M in a Series C round.
The round was announced on 03/01/21.